Alverno Clinical Laboratories
Overview
Alverno Clinical Laboratories sponsors a self-funded health plan that covered 1,661 participants in plan year 2025, down 5% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.
- Plan type
- ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
- Participants
- 1,661 · prior year 1,740
- Plan year
- Begins January 1 · next renewal January 2027
- Health plans filed
- Alverno Clinical Laboratories Welfare Benefits Plan, plan 507 (1,661 participants)
- Stop-loss carrier
- Blue Cross Blue Shield of Illinios
- Broker compensation
- $75K across insured contracts
Insurance carriers
Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.
| Carrier | Coverage | Covered | Premium | Broker comp |
|---|---|---|---|---|
| Blue Cross Blue Shield of Illinios | Medical, HMO, PPO, Stop-loss | 1,433 | $14.0M | $62K |
| Delta Dental of Indiana | Dental | 1,573 | $649K | — |
| Unum Life Insurance Company | Long-term disability | 1,226 | $335K | $7K |
| Unum Life Insurance Company (short-Term) | Short-term disability | 449 | $208K | $6K |
| Securian Life Insurance Company (life) | Life, Short-term disability | 1,350 | $161K | — |
| Eyemed Vision Vare | Vision | 1,333 | $128K | — |
Pharmacy benefit estimate
StreamRX estimate for a plan this size. Not based on this plan's claims.
Estimated prescription spend: 1,661 participants × $2,371 national average per member. Usually higher once dependents are counted.
Typical savings opportunity found in independent reviews of plans this size.
Form 5500 filing details
- Filing
- Form 5500 with Schedule A, plan year 2025
- Plan sponsor
- Alverno Clinical Laboratories
- Sponsor EIN
- 20-3240648
- Plan number
- 507
- Filed with
- U.S. Department of Labor (EBSA) via EFAST2
Verify this filing: search EIN 20-3240648 in the Department of Labor's EFAST2 Form 5500 search.
About this data
Source: Alverno Clinical Laboratories's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Alverno Clinical Laboratories.